Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

NCT04921137 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

OTHER: No endocrine therapy
OTHER: Endocrine therapy

Sponsor

Ottawa Hospital Research Institute